Frankfurt - Delayed Quote EUR

Towa Pharmaceutical Co., Ltd. (6QC.F)

Compare
15.30
-0.20
(-1.29%)
As of 8:13:02 AM GMT+2. Market Open.
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
243,942,000
227,934,000
208,859,000
165,615,000
154,900,000
Cost of Revenue
155,886,000
146,551,000
136,145,000
95,429,000
89,448,000
Gross Profit
88,057,000
81,383,000
72,713,000
70,185,000
65,451,000
Operating Expense
66,898,000
63,735,000
67,199,000
50,980,000
45,527,000
Operating Income
21,159,000
17,648,000
5,514,000
19,205,000
19,924,000
Net Non Operating Interest Income Expense
-1,118,000
-850,000
-618,000
-222,000
-167,000
Pretax Income
24,367,000
24,459,000
4,605,000
22,246,000
18,728,000
Tax Provision
8,591,000
8,286,000
2,404,000
6,331,000
4,770,000
Net Income Common Stockholders
15,775,000
16,173,000
2,201,000
15,914,000
13,958,000
Diluted NI Available to Com Stockholders
15,775,000
16,173,000
2,201,000
15,914,000
13,958,000
Basic EPS
320.50
328.59
44.72
323.36
283.62
Diluted EPS
320.50
328.59
44.72
316.19
271.93
Basic Average Shares
49,221.33
49,219.39
49,221.85
49,215.65
49,214.36
Diluted Average Shares
49,227.10
49,219.39
49,221.85
50,330.50
51,329.39
Total Operating Income as Reported
21,157,000
17,647,000
5,514,000
19,205,000
19,923,000
Total Expenses
222,784,000
210,286,000
203,344,000
146,409,000
134,975,000
Net Income from Continuing & Discontinued Operation
15,775,000
16,173,000
2,201,000
15,914,000
13,958,000
Normalized Income
15,107,496.57
12,515,026
4,033,448
14,674,190
15,695,340
Interest Income
193,000
97,000
17,000
8,000
23,000
Interest Expense
1,311,000
947,000
635,000
230,000
190,000
Net Interest Income
-1,118,000
-850,000
-618,000
-222,000
-167,000
EBIT
25,678,000
25,406,000
5,240,000
22,476,000
18,918,000
EBITDA
44,508,000
43,294,000
24,649,000
33,430,000
29,343,000
Reconciled Cost of Revenue
155,886,000
146,551,000
136,145,000
95,429,000
89,448,000
Reconciled Depreciation
18,830,000
17,888,000
19,409,000
10,954,000
10,425,000
Net Income from Continuing Operation Net Minority Interest
15,775,000
16,173,000
2,201,000
15,914,000
13,958,000
Total Unusual Items Excluding Goodwill
1,031,000
5,534,000
-2,386,000
1,734,000
-2,332,000
Total Unusual Items
1,031,000
5,534,000
-2,386,000
1,734,000
-2,332,000
Normalized EBITDA
43,477,000
37,760,000
27,035,000
31,696,000
31,675,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
363,496.57
1,876,026
-553,552
494,190
-594,660
3/31/2021 - 5/13/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CAIHF Chia Tai Enterprises International Limited
0.0100
0.00%
 
1MRK.MI Merck KGaA
119.60
-2.21%
 
0T01.F TILT Holdings Inc.
0.0110
0.00%
 
8Z1.F PharmaEssentia Corporation
0.0000
-100.00%
 
3D7.F Willow Biosciences Inc.
0.0025
+400.00%
 
2WU.F Lowell Farms Inc. R
0.0165
+73.68%
 
9SO.F Solasia Pharma K.K.
0.1720
-7.03%
 
4KF0.F Glass House Brands Inc.
4.2400
0.00%
 
AVCNF Avicanna Inc.
0.1760
-2.22%
 
BSPK Bespoke Extracts, Inc.
0.0633
0.00%